BCG Vaccine Market Poised for Growth, Expected to Reach USD 76 Million by 2030
According to Next Move Strategy Consulting, the global BCG Vaccine Market is projected to reach USD 76 million by 2030, expanding at a Compound Annual Growth Rate (CAGR) of 5% by 2030. BCG, or Bacille Calmette-Guérin, is a vaccine used for the prevention of tuberculosis (TB) and leprosy. Derived from the weakened Mycobacterium bovis bacterium, the vaccine plays a critical role in fighting these diseases, especially in regions where TB prevalence is high.
Download Free Sample: https://www.nextmsc.com/bcg-vaccine-market/request-sample
The BCG vaccine is administered in a non-invasive manner, involving a multi-pronged needle system that pricks the skin rather than using a traditional needle and syringe. This unique delivery method ensures the vaccine is administered directly into the superficial layers of the skin, providing protection against TB, as well as other infections like Buruli ulcer and certain cancers, particularly bladder cancer.
Market Dynamics and Growth Drivers
The increasing global prevalence of tuberculosis (TB) and rising bladder cancer cases are major factors driving the demand for BCG vaccines. According to the World Health Organization (WHO), approximately 10 million people were diagnosed with TB globally in 2020. Additionally, the growing number of newborns in developing nations, where TB poses a significant risk to infant health, has further fueled market growth. TB-related diseases, such as TB meningitis, can have severe outcomes in infants, including death, thus driving the demand for vaccination at birth.
Awareness campaigns initiated by global health organizations like UNICEF and WHO are also contributing to the rise in vaccine uptake. WHO’s designation of March 24 as World TB Day helps raise awareness about the devastating impacts of TB and the importance of the BCG vaccine in combatting the disease. Additionally, the launch of various initiatives, such as the LIFT-TB program, which aims to accelerate TB treatment efforts in high-risk regions, is likely to support market growth.
However, some adverse effects associated with the vaccine, such as swollen lymph glands and high fever, may limit the market's potential. Despite these side effects, the BCG vaccine remains the only globally available vaccine for tuberculosis, creating significant growth opportunities.
Inquire Before Buying: https://www.nextmsc.com/bcg-vaccine-market/inquire-before-buying
Market Segmentation and Insights
The BCG vaccine market is segmented into several categories:
- By Type: Immune BCG and Therapy BCG
- By Demographics: Pediatrics (0-18 years) and Adults (19-35 years)
- By Application: Tuberculosis and Bladder Cancer
- By Distribution Channel: Hospitals, Clinics, and Others
The Asia-Pacific region holds the largest market share, driven by high birth rates, high TB prevalence, and significant tobacco use, which increases the risk of lung infections. India, Bangladesh, and Southeast Asia are primary regions where the BCG vaccine plays a vital role in TB prevention. In India, where the national TB immunization program has long been in place, the demand for BCG vaccine continues to rise. In South Korea, government-backed initiatives are set to expand TB vaccine coverage.
North America also demonstrates steady growth due to rising tobacco consumption, which increases the likelihood of TB and related lung infections. The prevalence of bladder cancer, which BCG is used to treat, is another contributor to market expansion in the U.S. and Canada.
Competitive Landscape
The key players in the global BCG vaccine market include Sanofi Pasteur, Merck & Co., Inc., China National Biotec Group, Japan BCG Laboratory, InterVax Ltd., Serum Institute of India Pvt. Ltd., Biofabri, GreenSignal Bio Pharma Limited (GSBPL), AJ Biologics, and Torlak Institute of Virology. These companies are pursuing growth strategies such as product innovations, partnerships, and geographic expansion.
For example, in May 2022, the Serum Institute of India received approval for its Cy TB kit from India’s drug regulator, which can aid in diagnosing latent tuberculosis. This development is expected to drive demand for TB vaccines.
Conclusion
The BCG vaccine market is expected to see significant growth in the coming years due to rising global tuberculosis cases, the increasing prevalence of bladder cancer, and rising awareness around TB prevention. The market will also benefit from government initiatives and health campaigns aimed at tackling TB, especially in regions like Asia-Pacific. Despite challenges such as vaccine side effects, the BCG vaccine remains essential for global health, particularly in TB-endemic areas, and offers considerable market opportunities for stakeholders in the healthcare and pharmaceutical industries.
Also, Browse Related Reports:
For more information, please contact:
Next Move Strategy Consulting
E-Mail: info@nextmsc.com
Direct: +1-217-650-7991
Website: www.nextmsc.com
Follow Us: LinkedIn | Twitter | Facebook | Instagram | YouTube
About Next Move Strategy Consulting:
Next Move Strategy Consulting is a premier market research and management consulting firm that has been committed to provide strategically analysed well documented latest research reports to its clients. The research industry is flooded with many firms to choose from, what makes Next Move different from the rest is its top-quality research and the obsession of turning data into knowledge by dissecting every bit of it and providing fact-based research recommendation that is supported by information collected from over 500 million websites, paid databases, industry journals and one on one consultations with industry experts across a diverse range of industry sectors. The high-quality customized research reports with actionable insights and excellent end-to-end customer service help our clients to take critical business decisions that enables them to move beyond time and have competitive edge in the industry.
We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicates as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that range from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.